4//SEC Filing
Cramer Pamela J. 4
Accession 0001104659-25-110430
CIK 0001649904other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:30 PM ET
Size
17.7 KB
Accession
0001104659-25-110430
Insider Transaction Report
Form 4
Cramer Pamela J.
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-07$19.02/sh+8,805$167,471→ 29,619 total - Sale
Common Stock
2025-11-10$100.00/sh−3,515$351,500→ 20,814 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-11-07−8,805→ 5,257 totalExercise: $19.02Exp: 2031-07-25→ Common Stock (8,805 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2025-11-10−3,515→ 3,520 totalExercise: $6.80Exp: 2032-02-08→ Common Stock (3,515 underlying) - Exercise/Conversion
Common Stock
2025-11-07$6.80/sh+10,546$71,713→ 40,165 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-11-07−10,546→ 7,035 totalExercise: $6.80Exp: 2032-02-08→ Common Stock (10,546 underlying) - Sale
Common Stock
2025-11-07$98.82/sh−19,351$1,912,326→ 20,814 total - Exercise/Conversion
Common Stock
2025-11-10$6.80/sh+3,515$23,902→ 24,329 total
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.
- [F2]The stock option is fully vested.
- [F3]The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001873517
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:30 PM ET
- Size
- 17.7 KB